Scent-Free Formulation of Nasonex (Mometasone Furoate Monohydrate) Launched in US
KENILWORTH, NJ — January 12, 2005 — Schering-Plough Corporation (NYSE: SGP) today announced that the new scent-free, alcohol-free formulation of Nasonex® (mometasone furoate monohydrate) Nasal Spray, 50 mcg* is now available nationwide. The safety and efficacy of the scent-free, alcohol-free formulation was approved by the U.S. Food and Drug Administration (FDA) in August 2004.
Nasonex remains […]